Pages that link to "Q70965159"

The following pages link to Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo (Q70965159):

Displaying 32 items.

• The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. (Q24535769) (← links)
• Neurogenic inflammation: with additional discussion of central and perceptual integration of nonneurogenic inflammation (Q24545417) (← links)
• Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial (Q34132007) (← links)
• Role of endothelin-1 in acute lung injury. (Q34615080) (← links)
• Nasal potential difference to detect Na channel dysfunction in acute lung injury (Q34720193) (← links)
• Nasal potential difference in cystic fibrosis considering severe CFTR mutations (Q35033848) (← links)
• Relative ion permeability of normal and cystic fibrosis nasal epithelium (Q35207103) (← links)
• Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung (Q35325307) (← links)
• Silver/silver chloride electrodes for measurement of potential difference in human bronchi (Q35532103) (← links)
• Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. (Q35536342) (← links)
• The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition (Q36445182) (← links)
• Nasal Potential Difference Measurements to Assess CFTR Ion Channel Activity (Q37140714) (← links)
• Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus (Q37144432) (← links)
• Cigarette smoke and CFTR: implications in the pathogenesis of COPD (Q37234904) (← links)
• In situ measurement of airway surface liquid [K ] using a ratioable K -sensitive fluorescent dye (Q37257384) (← links)
• The impact of respiratory viral infections in patients with cystic fibrosis. (Q37289804) (← links)
• Assessment of the CFTR and ENaC association (Q37373358) (← links)
• Abnormalities of nasal potential difference measurement in Liddle's syndrome (Q37386830) (← links)
• Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience. (Q37419986) (← links)
• New clinical diagnostic procedures for cystic fibrosis in Europe (Q37887186) (← links)
• Systematic review and meta-analysis of nasal potential difference in hypoxia-induced lung injury (Q38917634) (← links)
• Reactive species and pulmonary edema (Q39639688) (← links)
• Movement of electrolytes and fluid across airways (Q40184950) (← links)
• Active transport of polypeptides in rabbit nasal mucosa: possible role in the sampling of potential antigens (Q42017686) (← links)
• Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease (Q43061300) (← links)
• Antisense oligonucleotides for therapy of cystic fibrosis. Inhibition of sodium absorption mediated by ENaC in nasal epithelial cells (Q43281629) (← links)
• A multiple reader scoring system for Nasal Potential Difference parameters. (Q46566814) (← links)
• Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects (Q72753429) (← links)
• Severe obstructive sleep apnea is associated with alterations in the nasal microbiome and an increase in inflammation (Q77790350) (← links)
• Ultrastructural characterization of epithelial cell membranes in normal human conducting airway epithelium: A freeze‐fracture study (Q84776835) (← links)
• Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis (Q89129500) (← links)
• Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies (Q89574920) (← links)